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–0.42). Age was the only independent predictor of reduced 
HRR at 1–5 min. In addition, WC predicted a reduced HRR at 
3 min. There were no significant associations between cen-
tral obesity and electrophysiological parameters. EFT was 
not associated with ANS dysfunction.  Conclusion: In this 
study, central adiposity and aging were associated with ANS 
dysfunction in obese individuals. The WC could be a marker 
of ANS dysfunction in obese individuals without any cardio-
vascular risk factors. The HRR assessment at a later decay 
phase could be more valuable for evaluating ANS function 
than during early recovery.  © 2016 S. Karger AG, Basel 
 Introduction 
 The autonomic nervous system (ANS) is thought to 
contribute to the pathophysiology of obesity  [1] . Increased 
adiposity had been linked to alterations in both sympa-
thetic and parasympathetic activities  [1, 2] . Decreased ad-
iposity after weight reduction has also been associated 
with improved ANS function  [3, 4] . Autonomic dysfunc-
tion can be assessed by various techniques, including heart 
rate variability (HRV), heart rate recovery (HRR), sympa-
thetic skin response (SSR), and R-R interval variation 
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 Abstract 
 Objective: To determine the relationship between central 
adiposity parameters and autonomic nervous system (ANS) 
dysfunction.  Subjects and Methods: The study included 114 
obese individuals without any cardiovascular risk factors. 
Weight (in kg), height (in m), and waist circumference (WC; 
in cm) were measured and body mass index was calculated. 
Echocardiographic examination was performed to measure 
left ventricular mass and epicardial fat thickness (EFT). All the 
participants underwent an exercise test and electrophysio-
logical evaluation using electromyography. Heart rate re-
covery (HRR) at 1–5 min, R-R interval variation at rest and 
during hyperventilation, and sympathetic skin response 
were measured. Pearson’s correlation analysis was used. 
Multiple linear regression analysis was used to identify the 
factors associated with autonomic dysfunction.  Results: The 
HRR at 1–5 min was negatively correlated with WC and age 
(WC-HRR1: r = –0.32; WC-HRR2: r = –0.31; WC-HRR3: r = –0.26; 
WC-HRR4: r = –0.23; WC-HRR5: r = –0.21; age-HRR2: r = –0.32; 
age-HRR3: r = –0.28; age-HRR4: r = –0.41; age-HRR5: r = 
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(RRIV)  [5] . The ability of specific measures of total or re-
gional body fat distribution, such as body mass index 
(BMI), waist circumference (WC), percent body fat, and 
visceral adipose tissue volume – in relation to HRV – to 
predict ANS function has been studied  [6–8] . Findings 
concerning the relationship between BMI and HRV have 
been inconsistent  [9, 10] . HRR, defined as the change in 
heart rate following exercise, is an indicator of cardiac au-
tonomic function and has been validated as a predictor of 
mortality  [11] . Epicardial fat thickness (EFT) is strongly 
correlated with visceral obesity, metabolic syndrome, dia-
betes mellitus, and cardiovascular disease  [12] . EFT can be 
measured using standard 2-dimensional echocardiogra-
phy. The precise pathophysiology and mechanisms un-
derlying increased mortality unrelated to cardiovascular 
risk factors associated with obesity remain unknown. A 
better understanding of the link between central adiposity 
parameters (i.e. EFT, WC) and autonomic dysfunction 
could help elucidate the mechanisms by which central ad-
iposity contributes to the risk of cardiovascular morbidity 
and mortality. The hypothesis of the present study was 
that parameters of central adiposity – including EFT – 
measured by echocardiography might be related to auto-
nomic dysfunction in obesity. Hence, the aim of the pres-
ent study was to evaluate autonomic function based on 
HRR, SSR, and RRIV, and to examine their relationships 
with parameters of central adiposity in obese individuals 
without any cardiovascular risk factors.
 Subjects and Methods 
 Patients 
 The study included 114 self-referred consecutive obese patients 
for weight loss. A power analysis was performed before the study. 
Accordingly, when effect size was considered moderate, 80 sub-
jects would have resulted in 95% confidence and 90% power. We 
included 114 subjects in the current study. The power analysis 
showed that our results when examined for significant correlations 
reached 95% confidence and 95% power. Exclusion criteria were 
cardiovascular disease (acute coronary syndrome, angina pectoris, 
any visible stenosis >20% in at least 1 coronary artery by angiogra-
phy, percutaneous or surgical revascularization, stroke, transient 
ischemic attack, and peripheral arterial disease), moderate (>2+) 
valvular regurgitation or any valvular stenosis, any rhythm other 
than sinus rhythm, systolic dysfunction (ejection fraction <50%), 
insufficient echocardiographic imaging, myocardial wall thinning 
or motion abnormalities (by echocardiography and suggestive of 
previous myocardial infarction), anemia, renal failure, hepatic fail-
ure, pregnancy or lactation, current or past smoking, regular use 
of alcohol, any systemic inflammatory condition, history of con-
ventional cardiovascular risk factors (including diabetes mellitus, 
obstructive sleep apnea, hypertension, hyperlipidemia, and meta-
bolic syndrome), major systemic or psychiatric disease, and use of 
any medication due to the potential confounding effects on ANS 
function. The study protocol was approved by the Medical Ethics 
Committee of the participating university and was performed in 
accordance with the Declaration of Helsinki, and all participants 
provided written informed consent. Unfortunately, we were not 
able to recruit a control group because the ethics committee would 
not allow us to perform painful invasive electrophysiological eval-
uation on healthy subjects.
 The participants were weighed in kg and their height was mea-
sured in m; then BMI was calculated. Obesity was defined as BMI 
>30. WC (cm) was measured midway between the lowest rib and 
the iliac crest while the participants were standing upright. Fasting 
plasma glucose and insulin levels were obtained on all participants. 
Then the homeostasis model assessment (HOMA) index was cal-
culated using the following formula: (fasting plasma glucose × fast-
ing plasma insulin)/22.5  [13] . The state of insulin resistance was 
determined using the cutoff value of 2.7.
 Exercise Treadmill Test 
 All the participants underwent exercise testing, with the goal of 
achieving  ≥ 85% of the age-predicted maximum heart rate accord-
ing to the standard or modified Bruce protocol  [14] . The partici-
pants were encouraged to exercise until they experienced limiting 
symptoms. Peak exercise was followed by a 2-min cooling down 
period of walking at 1.5 mph at a grade of 2.5%, as previously re-
ported  [15] . During each exercise stage and every minute for 5 min 
during recovery, blood pressure, heart rate, and cardiac rhythm 
were recorded. HRR at 1–5 min was defined as the difference be-
tween the heart rate during peak exercise and at 1–5 min of the 
recovery period. Typical anginal chest pain, >1 mm depression/
elevation of the ST segment, and arrhythmias were not observed 
in any of the participants during the exercise test.
 Echocardiographic Analysis 
 Echocardiographic examination at rest was performed in each 
participant while in the left lateral decubitus position, using stan-
dard views and a Vivid 7 echocardiography device (GE-Vingmed, 
Horten, Norway). Left ventricular mass (LVM), the LVM index, 
and LV wall thickness were calculated from 2-dimensional guided 
M-mode echocardiographic tracings obtained at the midchordal 
level in the parasternal long-axis view, according to American So-
ciety of Echocardiography criteria  [16] . All echocardiographic 
findings were analyzed by a single cardiologist (Y.T.Y.) who was 
blinded to clinical and laboratory characteristics of the patients. 
Intraobserver variability <5% was accepted for the echocardio-
graphic measurement. The LVM index was calculated using the 
corrected American Society of Echocardiography simplified cubed 
equation, and was indexed for body surface area using the software 
package of the device  [17] . Epicardial fat was considered the echo-
free space between the outer wall of the myocardium and the vis-
ceral layer of the pericardium, and EFT was measured perpendicu-
larly on the free wall of the right ventricle at end-systole in 3 car-
diac cycles, as previously described  [18] . The mean value of 3 
cardiac cycles from 2 echocardiographic views was calculated.
 Electrophysiological Evaluation 
 Electrophysiological evaluation of RRIV and SSR was per-
formed using a Medelec Synergy Nicolet EDX EMG device, ac-
cording to a protocol recommended by the International Federa-
tion of Clinical Neurophysiology  [19] .
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 RRIV Measurement 
 For heart rate variation during resting, the participants under-
went recording during 5 min of resting. For heart rate variation in 
response to breathing, the heart rate was recorded while the pa-
tients were breathing deeply at a rate of 6 breaths min –1 (inhala-
tion: 5 s; expiration: 5 s). After 8 deep breaths, each participant 
rested for 5 min and the test was repeated. The mean value of 2 
recordings was calculated.
 Recordings were made using 2 disc electrodes placed on the 
dorsum of each hand; filter settings were 20–100 Hz, sensitivity 
was 100 μV, and the sweep speed was 2 s division –1 . The RRIV was 
calculated using the formula, a/b × 100, where ‘a’ is the difference 
between the earliest and the latest appearing responses, and ‘b’ is 
the mean R-R interval. RRIV responses at rest and deep breathing 
were considered abnormal if >2 SD lower than the age-adjusted 
mean response in a normal population  [5] . The ratio of RRIV dur-
ing hyperventilation (HV) to RRIV at rest was defined as the HV-
RRIV ratio, and the difference between RRIV during HV and at 
rest was defined as the HV-RRIV difference.
 SSR Measurement 
 For palmar SSR, the median nerve was stimulated at a strength 
 ≥ 3-fold that of sensory threshold for 0.2 ms at 1 min –1 to avoid 
habituation, using disc electrodes placed on the palmar and dorsal 
surfaces of both hands; the filter settings were 0.2–100 Hz, sensitiv-
ity was 500 μV, and the sweep speed was 10 s division –1 . Amplitude 
 was measured peak to peak. The response was considered absent 
if no consistent voltage change occurred using a sensitivity of 50 
mV division –1 . Additionally, amplitude was considered abnormal 
when  ≥ 2 SD below the mean laboratory value.
 Statistical Analysis 
 Statistical analysis was performed using SPSS v.18.0 for Win-
dows (SPSS Inc., Chicago, Ill., USA). Continuous and categorical 
data are shown as means ± SD and percentages, respectively. The 
distribution of data was checked with a Kolmogorov-Smirnov test 
and, accordingly, Pearson’s correlation analysis was used to detect 
the relationship between continuous variables. Multiple linear re-
gression analysis was used to identify the factors associated with 
autonomic dysfunction. The level of statistical significance was set 
at p < 0.05. A multiple linear regression model was constructed to 
determine the relationship between the clinical and laboratory 
findings, and autonomic dysfunction.
 Results 
 The mean age of the 114 obese patients was 41.03 ± 
12.2 years and the mean BMI was 38.26 ± 6.35. Clinical 
and laboratory characteristics of the 114 participants are 
shown in  table 1 . There were weak significant negative 
correlations between HRR at 1–5 min, and WC and age 
(WC-HRR1: p = 0.001, r = –0.32; WC-HRR2: p = 0.002, 
r = –0.31; WC-HRR3: p = 0.01, r = –0.26; WC-HRR4: p = 
0.02, r = –0.23; WC-HRR5: p = 0.04, r = –0.21; age-HRR2: 
p = 0.001, r = –0.32; age-HRR3: p = 0.004, r = –0.28; age-
HRR4: p = 0.0001, r = –0.41; age-HRR5: p = 0.0001, r = 
–0.42). There was also a weak significant negative correla-
tion between age and the HV-RRIV ratio (p = 0.03, r = 
–0.22), and between age and the HV-RRIV difference
(p = 0.04, r = –0.21). There were no correlations between 
clinical and laboratory characteristics and RRIV, the HV-
RRIV ratio, and the HV-RRIV difference ( table 2 ).  Pear-
son’s correlation coefficients between WC and HRR at 
1–5 min are shown in  fig. 1 .
 The multiple linear regression model showed that age 
was the only independent predictor of reduced HRR at 
1–5 min, whereas age and WC were independent predic-
tors of HRR at 3 min ( table 3 ).
 Discussion 
 The findings showed that as a measure of central adi-
posity WC, but not EFT, was associated with greater ANS 
dysfunction. This relationship was observed primarily in 
terms of sympathetic activity. Overall adiposity, based on 
BMI, was not associated with either HRR or electrophys-
iological parameters. Thus, abdominal adiposity, as op-
posed to overall adipose tissue, could adversely affect 
ANS function.
 Table 1.  Clinical and laboratory characteristics of subjects (n = 
114) 
 Mean ± SD Median Range 
Age, years 40.9 ± 12.27 41.5 17 – 65
Male, n (%) 18 (16.1) – –
WC, cm 105.65 ± 11.42 104 83 – 129
BMI 38.08 ± 6.27 37 30 – 54
Systolic blood pressure, 
mm Hg 123.27 ± 13.37 120 100 – 139
Lifetime ASCVD risk, %1 
Women 28.81 ± 11.61 27 8 – 39
Men 37.7 ± 12.1 41 5 – 46
Laboratory measurements
Total cholesterol, mg/dl 188.19 ± 31 190 117 – 239
HDL-C, mg/dl 49.6 ± 14.5 48 5 – 91
LDL-C, mg/dl 111.81 ± 27.4 112 55 – 159
Triglycerides, mg/dl 132.15 ± 59.39 121 39 – 299
Fasting glucose, mg/dl 92.65 ± 5.82 94 68 – 99
Insulin, μIU/ml 15.03 ± 8.33 12.23 3.3 – 43.5
HOMA 3.46 ± 1.99 2.77 0.7 – 10.2
Creatinine, mg/dl 0.65 ± 0.13 0.60 0.4 – 1.1
 1 Lifetime risk estimates for atherosclerotic cardiovascular dis-
ease according to the race- and sex-specific pooled cohort equa-
tions, p = 0.015.
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 In this study, WC and age were associated with HRR 
at 1–5 min as reported in other studies  [6–8, 20, 21] , obe-
sity measurements were differently associated with HRV, 
WC was negatively correlated with HRV measurements, 
and WC predicted slower HRR at 3 min after exercise. 
Lindmark et al.  [20] reported that there was a positive 
correlation between visceral abdominal fat and a high 
sympathetic-parasympathetic ratio based on HRV assess-
ment, whereas subcutaneous abdominal fat was not as-
sociated with HRV measures. Christou et al.  [21] ob-
served higher abdominal to peripheral body fat distribu-
tion measured via dual-energy X-ray absorptiometry in 
young and old healthy males, which was strongly corre-
lated with lower sympathetic and parasympathetic func-
tion that explained a significant portion of several aging-
related changes in ANS. Windham et al.  [8] reported that 
increasing WC, but not BMI, was associated with de-
creasing HRV variables in younger participants. Central 
adiposity might contribute to ANS declines early in life. 
A large-scale cross-sectional study that included appar-
 Table 2.  Relationships between clinical and laboratory characteristics and HRR at 1 – 5 min, RRIV, and during HV, the HV-RRIV ratio, 
and the HV-RRIV difference 
HRR1 HRR2 HRR3 HRR4 HRR5 RRIV HV  Ratio Difference
r p r p r p r p r p r p r p r p r p
Age –0.19 0.06 –0.32 0.001 –0.28 0.004 –0.41 0.0001 –0.42 0.0001 0.1 0.32 0.003 0.97 –0.22 0.03 –0.21 0.04
BMI –0.16 0.12 –0.19 0.06 –0.06 0.54 –0.06 0.55 –0.07 0.5 0.1 0.34 0.04 0.66 –0.13 0.22 –0.1 0.35
WC –0.32 0.001 –0.31 0.002 –0.26 0.01 –0.23 0.02 –0.21 0.04 0.06 0.59 0.003 0.97 –0.08 0.43 –0.1 0.33
NLR 0.1 0.38 0.15 0.18 0.15 0.18 0.15 0.16 0.17 0.13 –0.15 0.17 –0.05 0.66 0.15 0.17 0.05 0.67
PLR 0.14 0.21 0.2 0.07 0.15 0.16 0.21 0.06 0.24 0.03 –0.22 0.05 –0.16 0.16 0.16 0.14 –0.05 0.66
HOMA –0.09 0.36 –0.06 0.58 –0.04 0.67 –0.08 0.41 –0.06 0.56 –0.09 0.38 –0.12 0.24 –0.02 0.85 –0.08 0.42
LVM index –0.09 0.4 –0.08 0.4 –0.05 0.62 –0.06 0.54 –0.11 0.26 0.07 0.48 –0.02 0.81 –0.18 0.07 –0.12 0.24
Mean EFT –0.05 0.63 –0.09 0.42 –0.04 0.7 –0.13 0.24 –0.2 0.07 0.18 0.1 0.05 0.63 –0.2 0.06 –0.09 0.41
NLR = Neutrophil-to-lymphocyte ratio; PLR = platelet-to-lymphocyte ratio.
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ently healthy Korean adults reported that the waist-to-hip 
ratio and percentage of body fat mass were better indica-
tors of low HRV measures than BMI  [6] . Poliakova et al. 
 [7] showed that age, WC, and percentage of fat presented 
an independent association with HRV, whereas BMI pre-
sented no association. These findings indicate that altera-
tions in autonomic function not detected during rest 
might be observed following exercise. In addition, WC 
only predicted slower HRR at 3 min, not at 1 min, which 
is 1 min into recovery and preferred in most studies. This 
also could suggest that obesity-related autonomic dys-
function might be better evaluated during the second 
slow HRR decay phase. It has been suggested that early 
HRR indices (such as HRR at 1 min) could be considered 
as markers of cardiac parasympathetic outflow  [22] . In 
contrast, the second slow heart rate decay phase was 
thought to be associated with the gradual withdrawal of 
sympathetic activity and with the clearance of stress sys-
tem metabolites  [22] . As such, obesity might initially af-
fect only sympathetic activity, which might play an im-
portant role in the pathogenesis of obesity-associated 
ANS dysfunction  [22] .
 In the present study there were no significant correla-
tions between adiposity and the electrophysiological pa-
rameters such as SSR and RRIV obtained at rest, which 
might have been the large normal ranges for SSR and 
RRIV that were considered for analysis, or the lack of a 
control group. Furthermore, the patients were tested only 
once at the time of enrollment in the study; follow-up 
data were not obtained. Epicardial fat has significantly 
higher rates of lipolysis and lipogenesis than other types 
of visceral fat  [18] . Given its anatomical proximity to the 
heart, epicardial fat interacts locally with the coronary ar-
teries and the myocardium via paracrine or vasocrine 
pathways. The EFT is strongly correlated with visceral 
obesity, metabolic syndrome, diabetes mellitus, and car-
diovascular disease  [18, 23] . In this respect, a potential 
relationship between EFT and ANS dysfunction – if 
found in obesity independent of other risk factors – could 
explain increased mortality.
 In the present study, there was not a relationship be-
tween EFT and ANS function, which could be due to the 
release of compartment-specific alterations in the balance 
of sympathetic/parasympathetic outflow; WC could con-
tribute to ANS dysfunction to a greater degree than EFT. 
Increased parasympathetic dominance in the visceral 
compartment, and increased sympathetic tone in the tho-
racic and movement compartments could play a role in 
metabolic syndrome, including visceral fat accumulation 
 [20, 24, 25] . The ANS innervates fat depots that are posi-
tively associated with catecholamine production by the 
ANS  [26, 27] . The biologic mechanisms whereby visceral 
fat could contribute to ANS dysfunction might involve 
adipocytokines secreted by fat cells  [28] . Another reason 
for the lack of observation of an association between EFT 
 Table 3.  Multiple linear regression analysis to determine the inde-
pendent predictors of autonomic dysfunction in obese subjects 
 B Odds
ratio
95% CI 
(lower to upper)
p
HRR1 (R² = 0.56; p = 0.0001)
Cons 149.4 – 118.2 to 180.7 0.000
Age –0.9 –0.6  – 1.2 to –0.6 0.000
LR 0.2 0.1  – 0.1 to 0.5 0.179
BMI –0.2 –0.1  – 0.9 to 0.5 0.487
WC 0.2 0.1  – 0.2 to 0.6 0.335
HOMA –0.8 –0.1  – 2.7 to 1.1 0.388
M.Eft 0.4 0  – 1.5 to 2.3 0.684
HRR2 (R² = 0.58; p = 0.0001)
Cons 132.6 – 106.8 to 158.4 0.000
Age –0.8 –0.6 –1 to –0.5 0.000
LR 0.1 0.1  – 0.1 to 0.3 0.463
BMI –0.1 –0.1  – 0.7 to 0.4 0.645
WC 0.2 0.2  – 0.1 to 0.6 0.233
HOMA –1.2 –0.2  – 2.7 to 0.4 0.15
M.Eft 0 0  – 1.5 to 1.6 0.965
HRR3 (R² = 0.58; p = 0.0001)
Cons 109.7 – 82.6 to 136.9 0.000
Age –0.7 –0.6 –1 to –0.4 0.000
LR 0.1 0.1 –0.1 to 0.4 0.213
BMI –0.7 –0.3 –1.3 to –0.1 0.023
WC 0.5 0.4 0.1 to 0.9 0.011
HOMA –1.3 –0.2 –3 to 0.4 0.126
M.Eft –0.3 0 –2 to 1.3 0.693
HRR4 (R² = 0.47; p = 0.007)
Cons 109.2 – 84.3 to 134 0.000
Age –0.5 –0.4 –0.7 to –0.2 0.000
LR 0.2 0.2 0 to 0.4 0.095
BMI –0.4 –0.2 –1 to 0.1 0.12
WC 0.2 0.1 –0.2 to 0.5 0.359
HOMA –0.3 0 –1.8 to 1.3 0.741
M.Eft 0.2 0 –1.3 to 1.7 0.897
HRR5  (R² = 0.50; p = 0.003)
Cons 106.7 – 80.7 to 132.8 0.000
Age –0.6 –0.5 – 0.8 to –0.3 0.000
LR 0.2 0.2 – 0.1 to 0.4 0.131
BMI –0.4 –0.2 –1 to 0.2 0.179
WC 0.1 0.1 – 0.2 to 0.5 0.506
HOMA –0.2 0 – 1.9 to 1.4 0.766
M.Eft 1 0.1 – 0.6 to 2.6 0.203
Cons = Constant; LR = lifetime risk; M.Eft = mean epicardial 
fat thickness.
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and ANS function could be that EFT measurements are 
imperfect, representing only 1 planar dimension that is 
subject to probe angulation, adequate visualization of the 
cardiac structure, and the given phase of the cardiac cycle 
chosen to be measured. As such, EFT may not represent 
average fat thickness all around the heart and may not be 
accurate in its predictive value.
 The present findings could have significant practical 
applications; if it can be definitively shown that central 
obesity is inversely related to ANS dysfunction in the 
hearts of obese individuals, such a relationship could be 
considered as an early marker of cardiovascular distur-
bance in this patient population. The long-term sequelae 
of ANS dysfunction that manifest as lower HRV are un-
known, but might contribute to cardiovascular, lipid, and 
endocrine abnormalities, as these mechanisms are regu-
lated by the ANS. Relevant evidence had been reported in 
studies that demonstrate associations between lower 
HRV and coronary artery disease, heart failure, hyperlip-
idemia, hypertension, and prediabetic and diabetic states 
 [29, 30] .
 One limitation of the present study was the evaluation 
of HRR after exercise. While this might not be represen-
tative of long-term evaluation on 24-hour ECG monitor-
ing, it does provide some important data concerning 
long-term variability and fluctuation. Other limitations 
were the small sample size, which was predominantly fe-
males, precluding a gender analysis, and measurement of 
EFT using echocardiography, which is less accurate than 
CT. Larger-scale studies that include obese patients and 
healthy controls are needed to confirm the present find-
ings.
 Conclusion 
 In this study, central adiposity (WC, but not EFT) was 
associated with ANS dysfunction; this relationship was 
observed primarily in terms of sympathetic activity. As 
such, we speculate that WC might be more strongly as-
sociated with ANS dysfunction than EFT, and might be 
an important mechanism in the pathogenesis of increased 
mortality in obesity. The second slow HRR decay phase 
might be more useful than early HRR indices for evaluat-
ing ANS function. Additional research targeting central 
adiposity for the prevention or attenuation of ANS dys-
function at an earlier stage in obese individuals may be 
warranted.
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